CCCC Stock Summary and Trading Ideas (C4 Therapeutics | NASDAQ:CCCC)

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

What symbol and exchange does C4 Therapeutics shares trade?

C4 Therapeutics trades on the NASDAQ stock market under the symbol CCCC.

What is C4 Therapeutics stock price doing today?

As of February 27, 2026, CCCC stock price climbed to $2.83 with 1,434,643 million shares trading.

What is C4 Therapeutics's Beta?

CCCC has a beta of 2.58, meaning it tends to be more sensitive to market movements. CCCC has a correlation of 0.21 to the broad based SPY ETF.

How much is C4 Therapeutics worth?

CCCC has a market cap of $263.38 million. This is considered a Small Cap stock.

How much money does C4 Therapeutics make?

Last quarter C4 Therapeutics reported $11 million in Revenue and -$.18 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.23.

What is the highest and lowest price C4 Therapeutics traded in the last 3 year period?

In the last 3 years, CCCC traded as high as $11.88 and as low as $1.06.

What are the top ETFs holding C4 Therapeutics?

The top ETF exchange traded funds that CCCC belongs to (by Net Assets): VTI, VXF, IBB, SCHA, PRFZ.

Is C4 Therapeutics (CCCC) a good investment?

CCCC has underperformed the market in the last year with a return of +6.8%, while SPY returned +16.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CCCC shares. However, CCCC has outperformed the market in the last 3 month and 2 week periods, returning +5.6% and +54.6%, while SPY returned +1.2% and +0.6%, respectively. This indicates CCCC has been having a stronger performance recently.

What are the support and resistance levels for C4 Therapeutics (CCCC)?

CCCC support price is $2.62 and resistance is $2.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CCCC shares will trade within this expected range on the day.